Phase
Condition
Seizure Disorders
Epilepsy
Treatment
LIFUP
Clinical Study ID
Ages 18-60 All Genders
Study Summary
Eligibility Criteria
Inclusion
Inclusion Criteria:
Subjects with clinical evidence from their diagnostic evaluations of unilateralhippocampal dysfunction and epileptogenicity.
Subjects with seizures that have been refractory to treatment with at least threecurrently marketed antiepileptic drugs.
Subjects with epilepsy who would clearly benefit from surgical intervention.
Subjects who have been offered a non-dominant anterior-mesial temporal loberesection as treatment for medication refractory epilepsy.
Exclusion
Exclusion Criteria:
Subjects with a cognitive or psychiatric disorder that limits the ability to giveinformed consent or are unable to cooperate with the testing.
Subjects with dementia, delirium and psychotic symptoms. - Subjects withferromagnetic materials in the head.
Subjects with severe cardiac disease, increased intracranial pressure, or a TENSunit.
Subjects who exhibit primary generalized seizures or pseudoseizures.
Subjects who have seizures secondary to drugs, alcohol, metabolic illness orprogressive degenerative disease.
Subjects who have experienced status epilepticus during the 3-week baseline periodprior to the operation.
Subjects (females) who are pregnant.
Study Design
Connect with a study center
UCLA
Los Angeles, California 90095
United StatesSite Not Available
Not the study for you?
Let us help you find the best match. Sign up as a volunteer and receive email notifications when clinical trials are posted in the medical category of interest to you.